T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBBY
2426
DELISTED
Bed Bath & Beyond Inc
BBBY
| $263K | ﹤0.01% |
42,961
-5,243
| -11% | -$42.7K |
|
|
LUCK
2427
Lucky Strike Entertainment
LUCK
$930M
| $262K | ﹤0.01% |
21,277
+3,265
| +18% | +$39K |
|
|
CTO
2428
CTO Realty Growth
CTO
$823M
| $261K | ﹤0.01% |
13,907
+1,079
| +8% | +$22.5K |
|
2429
Hingham Institution for Saving
HIFS
$686M
| $261K | ﹤0.01% |
1,039
-778
| -43% | -$227K |
|
2430
Bank of N.T. Butterfield & Son
NTB
$2.51B
| $261K | ﹤0.01% |
+8,010
| New | +$266K |
|
|
EB
2431
DELISTED
Eventbrite
EB
| $260K | ﹤0.01% |
42,666
-617,881
| -94% | -$5.2M |
|
|
TSP
2432
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $260K | ﹤0.01% |
34,145
+13,396
| +65% | +$112K |
|
2433
Codexis
CDXS
$175M
| $259K | ﹤0.01% |
42,714
+23,351
| +121% | +$188K |
|
2434
Clearfield
CLFD
$390M
| $259K | ﹤0.01% |
+2,471
| New | +$240K |
|
2435
Clean Energy Fuels
CLNE
$395M
| $259K | ﹤0.01% |
48,370
-9,707
| -17% | -$60.8K |
|
|
EGLE
2436
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $259K | ﹤0.01% |
5,980
+1,399
| +31% | +$66.2K |
|
|
CHS
2437
DELISTED
Chicos FAS, Inc.
CHS
| $257K | ﹤0.01% |
52,924
+7,398
| +16% | +$41.1K |
|
|
SRDX
2438
DELISTED
Surmodics
SRDX
| $256K | ﹤0.01% |
8,419
+799
| +10% | +$27.4K |
|
2439
VEON
VEON
$3.93B
| $256K | ﹤0.01% |
31,928
| – | – |
|
|
ACCD
2440
DELISTED
Accolade Inc
ACCD
| $256K | ﹤0.01% |
22,360
+4,687
| +27% | +$51.1K |
|
2441
Bally's
BALY
$660M
| $255K | ﹤0.01% |
+12,859
| New | +$295K |
|
2442
Pitney Bowes
PBI
$2.28B
| $255K | ﹤0.01% |
109,260
+10,324
| +10% | +$33.1K |
|
2443
Designer Brands
DBI
$312M
| $254K | ﹤0.01% |
16,571
-2,506
| -13% | -$39.3K |
|
2444
Stagwell
STGW
$2.28B
| $254K | ﹤0.01% |
36,524
-11,827
| -24% | -$76.3K |
|
|
CSII
2445
DELISTED
Cardiovascular Systems, Inc.
CSII
| $254K | ﹤0.01% |
18,310
+2,353
| +15% | +$34.9K |
|
2446
Asure Software
ASUR
$251M
| $253K | ﹤0.01% |
44,180
+6,700
| +18% | +$36.6K |
|
2447
Fulgent Genetics
FLGT
$513M
| $253K | ﹤0.01% |
6,631
+1,378
| +26% | +$69.1K |
|
2448
Mirum Pharmaceuticals
MIRM
$6.02B
| $253K | ﹤0.01% |
+12,031
| New | +$290K |
|
2449
Greenlight Captial
GLRE
$512M
| $252K | ﹤0.01% |
33,844
+7,745
| +30% | +$59K |
|
2450
JELD-WEN Holding
JELD
$170M
| $252K | ﹤0.01% |
28,784
-2,395,386
| -99% | -$31.4M |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.